Hmmmm. Two thoughts to ponder. First is the majority of firms in the Alerian have little to in some cases NO direct contact with oil. Mostly NG and NGLs. Second you think that the daily price movements are rational? Really. The public does not understand and moves like a chicken from one thing to another. Sorry you are angry, but it won't help. Chill out.
EPD is certainly oil related, but midstream MLPs actually own little oil. The question for midstreamers is counterparty default. not any problem with their contracts. EPD is probably 90% NG and NGLs.
What is the $%^^& are you talking about. The number set by the FDA was 484 and the FDA then reduced it. AMPE enrolled 480. That gives then a cushion of 16 patients if some drop out. No prediction of the outcome, but your post is showing a lack of reading skills.
Wow! Interesting since MLPs pay distributions that are very different and taxed completely differently from dividends. Earnings - why do you care? What is important is DCF as long as ETP can continue to borrow at IGrade status. Waiting Zacks stupid reports saying revenue was down.
Reduced guidance on distribution for 2016. Going to issue a ton of units to MPC for the new marine dropdown. Refused guidance for 2017. Stuttered and stammered through the conference call. It was an terrible call with information not provided. Wonder if they have any idea where they are going.
Thus they project 12% for 2016 and nothing beyond any longer. Just silence.
MWE/MPLX does get effected by product as when products are worth little they do not process say for ethane. Also many contracts in TX and OK they get a % of proceeds or even worse pay for the energy value they take out (KW contracts) and today are losing money on these today. Last, volumes are dropping in some areas because producers are not shipping and in NE there is not enough takeaway so producers are only receiving about 50% of spot market.
Thus the significant training that AMPE did prior to this trial to attempt to reduce the subjectivity of the ratings. This according to AMPE and suggested by the FDA. Guess soon we will see.